Zobrazeno 1 - 10
of 61
pro vyhledávání: '"A. G. Rekhtina"'
Publikováno v:
Онкогематология, Vol 18, Iss 4, Pp 225-232 (2023)
Background. The problem of hemostasis system pathology in patients with AL amyloidosis (AL-A) is of great practical importance. Currently, there are no recommendations concerning indications and methods of prevention of thrombotic complications.Aim.
Externí odkaz:
https://doaj.org/article/f0c408803f7d48f687aa97628a5741ef
Autor:
Irina G. Rekhtina, Victoria A. Khyshova, Nadezhda I. Zozulya, Valentina N. Dvirnyk, Larisa P. Mendeleyeva
Publikováno v:
Терапевтический архив, Vol 95, Iss 9, Pp 746-750 (2023)
Aim. To analyze the frequency and nature of hemorrhagic and thrombotic complications in patients with systemic AL-amyloidosis and compare with laboratory changes in the hemostasis system. Materials and methods. The prospective study included 40 pa
Externí odkaz:
https://doaj.org/article/26adafdf0ba8425b9a2a4b45f43ce5e5
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 83-88 (2022)
Neutrophilic leukocytosis is not specific for multiple myeloma (MM) and is a reason for the exclusion of myeloproliferative neoplasm.A clinical case of MM patient with neutrophilic hyperleukocytosis (75 х 109/L), liver and spleen enlargement at the
Externí odkaz:
https://doaj.org/article/cf5f3282a05e4d4b80e01f53f5234f8c
Autor:
Irina G. Rekhtina, Larisa P. Mendeleeva, Natalia P. Soboleva, Irina A. Dubina, Margarita Iu. Pervakova, Sergey V. Lapin
Publikováno v:
Терапевтический архив, Vol 94, Iss 1, Pp 135-144 (2022)
Paraprotein is a laboratory biomarker of plasma cell tumors and other lymphoproliferative diseases. Its determination is necessary for diagnosing, monitoring and assessment of therapy effectiveness. The lecture presents the main methods of qualitativ
Externí odkaz:
https://doaj.org/article/bb533588785a457d9e1905df8bb28b28
Publikováno v:
Онкогематология, Vol 16, Iss 3, Pp 74-82 (2021)
Objective of the study: analysis of AL-amyloidosis (AL-A) diagnostics in real clinical practice and to determine the main approaches for the earlier detection of this disease.Materials and methods. A retrospective analysis of medical records of 34 pa
Externí odkaz:
https://doaj.org/article/96f5f7a1f70d4719a864d17f6036b3d6
Autor:
Larisa P. Mendeleeva, Olga M. Votiakova, Irina G. Rekhtina, Evgenii A. Osmanov, Irina V. Poddubnaya, Liudmila Iu. Grivtsova, Natalia A. Falaleeva, Vadim V. Baikov, Alla M. Kovrigina, Aleksei A. Nevol’skikh, Sergei A. Ivanov, Zhanna V. Khailova, Tigran G. Gevorkian
Publikováno v:
Современная онкология, Vol 22, Iss 4, Pp 6-28 (2021)
Multiple myeloma
Externí odkaz:
https://doaj.org/article/26aa1c3ad2d043418a72f9f31ef3b5f4
Autor:
I. G. Rekhtina, E. V. Kazarina, E. S. Stolyarevich, A. M. Kovrigina, V. N. Dvirnyk, S. M. Kulikov, L. P. Mendeleeva
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 63-69 (2020)
Aim.Reveal morphological and immunohistochemical predictors of reversibility of dialysis-dependent acute kidney injury (AKI) in patients with myeloma cast nephropathy (MCN) based on the study of kidney biopsy. Materials and methods.Renal pathologi
Externí odkaz:
https://doaj.org/article/334f035c8652478d9f44c3b8758a6230
Autor:
L. P. Mendeleeva, I. G. Rekhtina, A. M. Kovrigina, I. E. Kostina, V. A. Khyshova, N. K. Arytyunyan, W. E. Mamonov, V. G. Savthenko
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 85-89 (2020)
Our case demonstrates severe bone disease in primary AL-amyloidosis without concomitant multiple myeloma. A 30-year-old man had spontaneous vertebral fracture Th8. A computed tomography scan suggested multiple foci of lesions in all the bones. In bon
Externí odkaz:
https://doaj.org/article/ca469b7fe02e42c69d464ad1eb4cb5da
Autor:
M. V. Firsova, L. P. Mendeleeva, M. V. Solovev, I. G. Rekhtina, O. S. Pokrovskaya, E. S. Urnova, N. P. Soboleva, V. N. Dvirnyk, G. A. Klyasova, L. A. Kuzmina, V. G. Savchenko
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 70-76 (2020)
Aim.To assess the safety and efficacy of autologous haematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with dialysis-dependent renal failure. Materials and methods.During a period from May 2010 to December 2016
Externí odkaz:
https://doaj.org/article/a01f94a3ddbe462b9ab261e3486d0445
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 70-74 (2019)
Aim: to determine serum free light chains (FLC) level by patients with multiple myeloma (MM) and dialysis - dependent renal impairment in which the amount Bence Jones (BJ) protein in the urine met the criteria of hematological response. Patients and
Externí odkaz:
https://doaj.org/article/8769e7316e044f5ba326e6158c13453f